Wealth Enhancement & Preservation Of Ga, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Wealth Enhancement & Preservation Of Ga, LLC

$104 Million
Q2 2023

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Oct 13, 2020	SELL	$544.75 - $658.21 $1.68 Million - $2.04 Million	-3,092 Closed	0 $0
Q2 2020 Sep 08, 2020	BUY	$493.32 - $643.92 $1.53 Million - $1.99 Million	3,092 New	3,092 $1.91 Million

Others Institutions Holding REGN

# of Institutions

1,463

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

Vanguard Group Inc Valley Forge, PA

8.99M
Shares

$9.13 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

8.45M
Shares

$8.57 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

8.28M
Shares

$8.4 Billion
0.77% of portfolio
State Street Corp Boston, MA

4.84M
Shares

$4.91 Billion
0.23% of portfolio
Capital World Investors Los Angeles, CA

4.64M
Shares

$4.71 Billion
0.82% of portfolio

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $109B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Enhancement & Preservation Of Ga, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Enhancement & Preservation Of Ga, LLC with notifications on news.

Account